Boeing's shares rose modestly by 1.2% after its Q2 report as the company made steady progress on certification milestones and production ramp-ups, though cost pressures on fixed-price defense programs and a cautious supply chain update limited upside for investors.
- Commercial Airplanes production ramps continued with 737 MAX reaching 47 units per month and plans for 52 units monthly under way; 787 production stabilized at 8 units per month after temporary slowdown to aid supply chain recovery.
- Certification progress remains on track with FAA approvals for 737-7 and -10 variants pending and 55% of 777-9 flight testing completed, supporting deliveries expected in 2027.
- Defense and Space secured low-rate initial production approvals for T-7 and MQ-25 and advanced KC-46A upgrades, although the VC-25B program incurred a $280 million charge due to increased costs and schedule risk mitigation.
- Supply chain transparency efforts continue but remain critical as temporary production slowdowns highlight ongoing vulnerabilities.
- Boeing reiterated a constructive demand outlook with a backlog above 6,200 airplanes and a commercial market forecast near 44,000 new planes over 20 years.
Community Discussion